3 news items
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ADIL
AEYE
ATHE
15 Apr 24
. (NASDAQ:EGIO) gained 24% to $22.18.
Kaival Brands Innovations Group, Inc
Longeveron Issues Letter To Shareholders Highlighting Corporate Strategy, Clinical Pipeline And 2024 Key Priorities And Goals
LGVN
8 Apr 24
far, and I am immensely grateful for the opportunity to lead such a pioneering organization dedicated to transforming healthcare through innovations
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
LGVN
8 Apr 24
to transforming healthcare through innovations in regenerative medicine. Upon joining Longeveron, I set out with a clear objective: to develop
- Prev
- 1
- Next